[Pandemic scenarios].
Robert Koch Institutes, Influenza-Abteilung beim RKI.
Werner
W
Lange
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003140:Communicable Disease Control / Q000458:organization & administration*; D004196:Disease Outbreaks; D005858:Germany; D006285:Health Planning / Q000458:organization & administration*; D006287:Health Planning Guidelines; D006801:Humans; D053121:Influenza A Virus, H2N2 Subtype; D053122:Influenza A Virus, H3N2 Subtype; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000401:mortality / Q000451:nursing* / Q000517:prevention & control; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D016019:Survival Analysis; D014944:World Health Organization
D000998:Antiviral Agents; D007252:Influenza Vaccines; D009439:Neuraminidase